TG THERAPEUTICS INC. - COMMON STOCK

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

10 апр 2025 07:30:00 Источник Nasdaq GlobeNewswire

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

08 апр 2025 07:30:00 Источник Nasdaq GlobeNewswire

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

07 апр 2025 07:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

24 мар 2025 10:29:34 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

21 мар 2025 16:10:11 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

20 мар 2025 09:57:38 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

19 мар 2025 15:08:13 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

14 мар 2025 12:51:58 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

10 мар 2025 09:46:35 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

07 мар 2025 14:46:14 Источник NetDania Notify

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

07 мар 2025 07:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

06 мар 2025 11:21:26 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

04 мар 2025 10:46:23 Источник NetDania Notify

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

03 мар 2025 07:00:00 Источник Nasdaq GlobeNewswire

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

27 фев 2025 07:30:00 Источник Nasdaq GlobeNewswire

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

26 фев 2025 07:30:00 Источник Nasdaq GlobeNewswire

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

18 фев 2025 07:30:00 Источник Nasdaq GlobeNewswire

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

14 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

09 янв 2025 07:30:00 Источник Nasdaq GlobeNewswire

TG Therapeutics to Participate in the Evercore HealthCONx Conference

29 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire